ivabradine has been researched along with darapladib in 1 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (darapladib) | Trials (darapladib) | Recent Studies (post-2010) (darapladib) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 104 | 28 | 81 |
| Protein | Taxonomy | ivabradine (IC50) | darapladib (IC50) |
|---|---|---|---|
| Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 0.0003 | |
| Platelet-activating factor acetylhydrolase | Mus musculus (house mouse) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dulsat, C | 1 |
1 other study(ies) available for ivabradine and darapladib
| Article | Year |
|---|---|
A report from the European Society of Cardiology Congress 2014 (August 30-September 3 - Barcelona, Spain).
Topics: Aminobutyrates; Benzaldehydes; Benzazepines; Biphenyl Compounds; Cardiology; Cardiovascular Diseases; Drug Combinations; Enalapril; Humans; Ivabradine; Oximes; Stents; Tetrazoles; Valsartan | 2014 |